This presentation explores the pathophysiology of androgenetic alopecia and the limitations of conventional therapies. It focuses on regenerative approaches, emerging biologic strategies, and novel targeted treatments, within the broader field of emerging therapies in hair loss. Clinical evidence, patient selection, and outcome assessment tools such as trichoscopy are discussed to provide a practical framework for daily practice. The session aims to bridge scientific advances with real-world clinical application.